Ecleralimab

(Synonyms: CSJ-117; NVP-CSJ117)
Customer Review

Based on 1 Customer Validation

Ecleralimab (CSJ-117; NVP-CSJ117) is a Fab-IgG1-λ2 antibody targeting the thymic stromal lymphopoietin (TSLP). Ecleralimab significantly attenuates allergen-induced airway responses and inflammation. Ecleralimab can be used for the study of inhaled asthma.

For research use only. We do not sell to patients.

  • Purity: 97.35%
  • CAS No.: 2415207-91-7
  • Molecular Weight:46.62 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00